Singleton Merten syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Singleton-Merten syndrome
Synonyms Singleton-Merten dysplasia
Pronounce
Specialty Medical genetics
Symptoms Aortic valve calcification, dental dysplasia, osteoporosis, psoriasiform rash
Complications N/A
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Rheumatic fever, Marfan syndrome, Ehlers-Danlos syndrome
Prevention N/A
Treatment Symptomatic treatment, dental care, cardiac monitoring
Medication N/A
Prognosis Variable, depends on severity
Frequency Rare
Deaths


Singleton Merten syndrome is a rare genetic disorder characterized by a combination of dental anomalies, osteoporosis, and calcification of the aorta and heart valves. The syndrome was first described by Singleton and Merten in 1973.

Presentation[edit]

Individuals with Singleton Merten syndrome typically present with a variety of symptoms, including:

Genetics[edit]

Singleton Merten syndrome is inherited in an autosomal dominant manner. Mutations in the IFIH1 gene have been identified as a cause of the syndrome. The IFIH1 gene is involved in the body's immune response to viral infections.

Diagnosis[edit]

Diagnosis of Singleton Merten syndrome is based on clinical evaluation, family history, and genetic testing. Imaging studies such as X-rays and echocardiograms are used to assess bone density and heart valve calcification.

Management[edit]

There is no cure for Singleton Merten syndrome, and treatment is primarily supportive. Management may include:

Prognosis[edit]

The prognosis for individuals with Singleton Merten syndrome varies depending on the severity of symptoms and the presence of complications such as heart valve calcification. Early diagnosis and management can improve quality of life.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.